Although we found a significant predictive ability of neprilysin for adverse CV outcomes in HD patients, recent studies on non-dialysis-dependent CKD revealed that high neprilysin levels did not predict poor CV outcomes (33). This evidence concerns the gene MME and chronic kidney disease.